Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04281823 · ClinicalTrials.gov registry record
DeBakey Cardiovascular Magnetic Resonance Study
A clinical trial of Cardiovascular Diseases, sponsored by Dipan Shah.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT04281823: Recruiting study of Cardiovascular Diseases, sponsored by Dipan Shah.
NCT04281823 is a study of Cardiovascular Diseases that is actively recruiting participants, run by Dipan Shah. The registered enrollment target is 100,000 participants, above the 26,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (275% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04281823, a study of Cardiovascular Diseases, is actively recruiting participants, sponsored by Dipan Shah.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
While advancements in cardiac magnetic resonance (CMR) have improved image quality, it is unclear how these improvements are connected to the clinical evaluation of individuals with cardiovascular disease. The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to gain additional pathophysiologic insights into cardiovascular disease, 2) understand how CMR compares to alternative cardiovascular diagnostic modalities, 3) determine how CMR affects clinical management decisions, and 4) establish a link between CMR findings and long term prognosis in patients with known or suspected cardiovascular disease. The ultimate aim is to utilize CMR to improve patient outcomes. CMR techniques to be studies include function, fibrosis, and flow. Focus areas include valvular heart disease, ischemic heart disease, cardiomyopathies, and vascular disease.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiovascular Magnetic Resonance
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2008-04-01 |
| Est. Completion | 2058-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04281823
The ClinicalTrials.gov registry entry for NCT04281823 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 26,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (275% higher). The listed sponsor is Dipan Shah, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular Magnetic Resonance is the first listed.
NCT04281823 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04281823 about?
NCT04281823 is a clinical study titled "DeBakey Cardiovascular Magnetic Resonance Study". While advancements in cardiac magnetic resonance (CMR) have improved image quality, it is unclear how these improvements are connected to the clinical evaluation of individuals with cardiovascular disease. The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to...
What is the current status of trial NCT04281823?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2008-04-01. Estimated completion is 2058-04-01.
What conditions does trial NCT04281823 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT04281823?
The interventions under investigation include: Cardiovascular Magnetic Resonance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04281823?
This trial is sponsored by Dipan Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04281823 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.